Lexaria Bioscience Corp. Balance Sheet
LEXX|10 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
Lexaria Bioscience Corp. had $4M in total assets and $3M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | $5.8M | $1.3M | $1.3M | $1.7M | $260.1K | $260.1K | $703.0K |
| Accounts Receivable | $368.4K | $154.5K | $175.2K | $201.8K | $342.4K | $313.9K | $273.1K | $45.3K | $131.1K | $31.4K |
| Inventory | - | - | - | $38.4K | $29.6K | $116.9K | $127.4K | $67.2K | $134.7K | $168.0K |
| Current Assets | $3.5M | $7.9M | $2.2M | $7.0M | $12.4M | $1.9M | $1.8M | $2.8M | $510.2K | $674.7K |
| PP&E (Net) | $228.1K | $254.7K | $254.1K | $315.5K | $368.2K | $483.4K | $591.3K | $1.9K | $2.5K | - |
| Total Assets | $4.2M | $8.9M | $3.1M | $7.8M | $13.3M | $2.8M | $2.7M | $2.9M | $566.6K | $711.7K |
| Current Liabilities | $1.5M | $1.1M | $267.7K | $194.0K | $153.3K | $225.9K | $184.5K | $92.3K | $433.9K | $55.1K |
| Shareholders' Equity | $3.0M | $8.0M | $3.0M | $13.3M | $2.5M | $2.4M | $2.8M | $3.0M | $266.0K | $772.4K |